| Financial Year |
March 31 2023 |
| Monetary Funds |
18,043,402,241.25 |
| Held-for-trading Financial Assets |
34,644,444,999.12 |
| Notes Receivable |
-- |
| Accounts Receivable |
328,267,263.45 |
| Advances to Suppliers |
92,390,126.26 |
| Other Receivables |
159,812,539.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
6,000,834.26 |
| Dividend Receivable |
189,731.04 |
| Inventories |
49,758,749.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
21,670,582,895.39 |
| Other Current Assets |
13,697,756,396.71 |
| Total Current Assets |
96,800,979,505.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
34,992,805,233.00 |
| Long-term Equity Investment |
4,614,654,009.44 |
| Investment Properties |
344,513,987.53 |
| Fixed Assetes |
341,088,568.90 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
542,539,237.52 |
| R&D expenses |
7,805,496.44 |
| Goodwill |
1,411,965,090.33 |
| Long-Term Deferred and Prepaid Expenses |
76,545,013.53 |
| Deferred Income Tax Assets |
2,184,360,379.96 |
| Other Non-Current Assets |
30,176,318.23 |
| Sub-Total of Non-Current Assets |
63,406,695,947.84 |
| Total Assets |
160,207,675,453.53 |
| Short-Term Loans |
39,716,242,153.01 |
| Trading Financial liabilities |
2,465,072,407.82 |
| Notes Payable |
133,650,000.00 |
| Accounts Payable |
76,003,958.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
786,026,192.41 |
| Taxes Payable |
749,036,645.40 |
| Interest Payable |
2,773,142.31 |
| Dividend Payable |
-- |
| Other payables |
668,527,822.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,198,382,269.77 |
| Other Current Liabilities |
17,922,275,347.00 |
| Sub-Total of Current Liabilities |
87,436,237,485.64 |
| Long-term Loans |
4,444,085,677.48 |
| Bonds Payable |
4,210,000,000.00 |
| Long-Term Accounts Payable |
2,151,927,541.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
605,334,927.17 |
| Deferred Income Tax Liabilities |
72,862,560.54 |
| Other Non-Current Liabilities |
1,199,612,259.96 |
| Sub-Total of Non-Current Liabilities |
13,082,703,718.20 |
| Total Liabilities |
100,518,941,203.84 |
| Paid-In Capital(Or Share Stock) |
4,498,065,459.00 |
| Capital Surplus |
21,317,516,410.01 |
| Surplus Reserve |
1,339,075,889.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,256,944,447.63 |
| Minority Stockholder's Interest |
10,239,303,155.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
49,449,431,094.33 |
| Owner's Equity（Stockholder's Equity） |
59,688,734,249.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
160,207,675,453.53 |
